Q3 2021 Iteos Therapeutics Inc Earnings Call Transcript
Good afternoon and welcome to the iTeos Therapeutics third-quarter 2021 financial results conference call. At this time, all participants are in listen-only mode. Following the formal remarks, we will open the call up for you for questions. Please be advised that this call is being recorded at the company's request.
At this time, I'd like to turn it over to Ryan Baker, Head of Investor Relations for Iteos. Ryan, please proceed.
Thank you, operator, and thank you, everyone, on the call for joining us today. Joining me from Iteos with prepared remarks are Michel Detheux, President and Chief Executive Officer; Jo Lager, Chief Medical Officer; and Matthew Gall, Chief Financial Officer.
Before we begin, the team will be making forward-looking statements in the prepared remarks and during the Q&A session. Any statements made during this call that are not statements of historical or current facts are intended to be forward-looking statements pursuant to the Safe Harbor provisions of the Private
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |